ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 235 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,482 | +9.2% | 36 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $14,174 | +0.7% | 36 | -2.7% | 0.00% | 0.0% |
| Q4 2023 | $14,076 | -24.7% | 37 | -2.6% | 0.00% | -50.0% |
| Q3 2023 | $18,682 | +19.8% | 38 | -5.0% | 0.00% | +100.0% |
| Q2 2023 | $15,590 | +13.1% | 40 | +8.1% | 0.00% | 0.0% |
| Q1 2023 | $13,786 | -1.6% | 37 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $14,017 | +7.8% | 37 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $13,000 | -7.1% | 37 | -2.6% | 0.00% | 0.0% |
| Q2 2022 | $14,000 | +27.3% | 38 | +11.8% | 0.00% | 0.0% |
| Q1 2022 | $11,000 | – | 34 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
| Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
| Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
| MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
| AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
| EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
| INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
| Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
| DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
| Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |